| UniProt ID | TB22A_HUMAN | |
|---|---|---|
| UniProt AC | Q8WUA7 | |
| Protein Name | TBC1 domain family member 22A | |
| Gene Name | TBC1D22A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 517 | |
| Subcellular Localization | ||
| Protein Description | May act as a GTPase-activating protein for Rab family protein(s).. | |
| Protein Sequence | MASDGARKQFWKRSNSKLPGSIQHVYGAQHPPFDPLLHGTLLRSTAKMPTTPVKAKRVSTFQEFESNTSDAWDAGEDDDELLAMAAESLNSEVVMETANRVLRNHSQRQGRPTLQEGPGLQQKPRPEAEPPSPPSGDLRLVKSVSESHTSCPAESASDAAPLQRSQSLPHSATVTLGGTSDPSTLSSSALSEREASRLDKFKQLLAGPNTDLEELRRLSWSGIPKPVRPMTWKLLSGYLPANVDRRPATLQRKQKEYFAFIEHYYDSRNDEVHQDTYRQIHIDIPRMSPEALILQPKVTEIFERILFIWAIRHPASGYVQGINDLVTPFFVVFICEYIEAEEVDTVDVSGVPAEVLCNIEADTYWCMSKLLDGIQDNYTFAQPGIQMKVKMLEELVSRIDEQVHRHLDQHEVRYLQFAFRWMNNLLMREVPLRCTIRLWDTYQSEPDGFSHFHLYVCAAFLVRWRKEILEEKDFQELLLFLQNLPTAHWDDEDISLLLAEAYRLKFAFADAPNHYKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MASDGARKQ ------CCCHHHHHH | 19.14 | 23572552 | |
| 12 | Ubiquitination | GARKQFWKRSNSKLP HHHHHHHHHCCCCCC | 47.43 | - | |
| 14 | Phosphorylation | RKQFWKRSNSKLPGS HHHHHHHCCCCCCCC | 41.55 | 24719451 | |
| 16 | Phosphorylation | QFWKRSNSKLPGSIQ HHHHHCCCCCCCCCE | 36.49 | 28857561 | |
| 21 | Phosphorylation | SNSKLPGSIQHVYGA CCCCCCCCCEEECCC | 19.69 | 28796482 | |
| 26 | Phosphorylation | PGSIQHVYGAQHPPF CCCCEEECCCCCCCC | 12.48 | 28796482 | |
| 44 | O-linked_Glycosylation | LHGTLLRSTAKMPTT HCHHHHHHCCCCCCC | 32.46 | 30379171 | |
| 50 | Phosphorylation | RSTAKMPTTPVKAKR HHCCCCCCCCCCCCE | 39.99 | 20068231 | |
| 51 | Phosphorylation | STAKMPTTPVKAKRV HCCCCCCCCCCCCEE | 21.88 | 20068231 | |
| 106 | Phosphorylation | NRVLRNHSQRQGRPT HHHHHHCHHHCCCCC | 30.52 | 24247654 | |
| 113 | Phosphorylation | SQRQGRPTLQEGPGL HHHCCCCCCCCCCCC | 39.45 | 23927012 | |
| 118 (in isoform 3) | Phosphorylation | - | 39.30 | 21406692 | |
| 128 (in isoform 2) | Phosphorylation | - | 36.96 | 22210691 | |
| 130 (in isoform 2) | Phosphorylation | - | 41.54 | 22210691 | |
| 131 (in isoform 2) | Phosphorylation | - | 51.47 | 22210691 | |
| 132 | Phosphorylation | RPEAEPPSPPSGDLR CCCCCCCCCCCCCCE | 61.22 | 29255136 | |
| 135 | Phosphorylation | AEPPSPPSGDLRLVK CCCCCCCCCCCEEEE | 48.61 | 22167270 | |
| 136 (in isoform 3) | Phosphorylation | - | 43.69 | 21406692 | |
| 143 | Phosphorylation | GDLRLVKSVSESHTS CCCEEEEECCCCCCC | 24.32 | 23927012 | |
| 145 | Phosphorylation | LRLVKSVSESHTSCP CEEEEECCCCCCCCC | 40.24 | 23401153 | |
| 147 | Phosphorylation | LVKSVSESHTSCPAE EEEECCCCCCCCCCC | 25.26 | 23927012 | |
| 149 | Phosphorylation | KSVSESHTSCPAESA EECCCCCCCCCCCCH | 41.10 | 23927012 | |
| 150 | Phosphorylation | SVSESHTSCPAESAS ECCCCCCCCCCCCHH | 16.81 | 23927012 | |
| 155 | Ubiquitination | HTSCPAESASDAAPL CCCCCCCCHHCCCCC | 34.87 | - | |
| 155 | Phosphorylation | HTSCPAESASDAAPL CCCCCCCCHHCCCCC | 34.87 | 23663014 | |
| 157 | Phosphorylation | SCPAESASDAAPLQR CCCCCCHHCCCCCCC | 36.74 | 28450419 | |
| 165 | Phosphorylation | DAAPLQRSQSLPHSA CCCCCCCCCCCCCCE | 15.91 | 25159151 | |
| 167 | Phosphorylation | APLQRSQSLPHSATV CCCCCCCCCCCCEEE | 45.15 | 23927012 | |
| 171 | Phosphorylation | RSQSLPHSATVTLGG CCCCCCCCEEEEECC | 24.56 | 30278072 | |
| 173 | Phosphorylation | QSLPHSATVTLGGTS CCCCCCEEEEECCCC | 19.62 | 30278072 | |
| 175 | Phosphorylation | LPHSATVTLGGTSDP CCCCEEEEECCCCCH | 18.48 | 30278072 | |
| 179 | Phosphorylation | ATVTLGGTSDPSTLS EEEEECCCCCHHHCC | 28.32 | 23927012 | |
| 180 | Phosphorylation | TVTLGGTSDPSTLSS EEEECCCCCHHHCCH | 51.29 | 23927012 | |
| 183 | Phosphorylation | LGGTSDPSTLSSSAL ECCCCCHHHCCHHHC | 47.15 | 23927012 | |
| 184 | Phosphorylation | GGTSDPSTLSSSALS CCCCCHHHCCHHHCC | 35.73 | 23927012 | |
| 186 | Phosphorylation | TSDPSTLSSSALSER CCCHHHCCHHHCCHH | 23.49 | 20068231 | |
| 187 | Phosphorylation | SDPSTLSSSALSERE CCHHHCCHHHCCHHH | 23.81 | 23927012 | |
| 188 | Phosphorylation | DPSTLSSSALSEREA CHHHCCHHHCCHHHH | 29.83 | 23927012 | |
| 191 | Phosphorylation | TLSSSALSEREASRL HCCHHHCCHHHHHHH | 34.03 | 23927012 | |
| 196 | Phosphorylation | ALSEREASRLDKFKQ HCCHHHHHHHHHHHH | 28.73 | 21406692 | |
| 202 | Ubiquitination | ASRLDKFKQLLAGPN HHHHHHHHHHHCCCC | 45.86 | - | |
| 219 | Phosphorylation | LEELRRLSWSGIPKP HHHHHHHHCCCCCCC | 19.86 | 20068231 | |
| 221 | Phosphorylation | ELRRLSWSGIPKPVR HHHHHHCCCCCCCCC | 24.38 | 20068231 | |
| 236 | Phosphorylation | PMTWKLLSGYLPANV CCCHHHHHCCCCCCC | 35.51 | 28857561 | |
| 288 | Phosphorylation | HIDIPRMSPEALILQ EEECCCCCHHHEECC | 22.37 | - | |
| 515 | Phosphorylation | FADAPNHYKK----- HCCCCCCCCC----- | 27.41 | 27642862 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TB22A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TB22A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TB22A_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |